Kepos Capital LP Ligand Pharmaceuticals Inc Transaction History

Kepos Capital LP

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2019 May 13, 2019	SELL	$105.93 - $142.47 $636,321 - $855,817	-6,007 Closed	0 $0
Q4 2018 Feb 13, 2019	SELL	$128.36 - $272.13 $2.2 Million - $4.67 Million	-17,166 Reduced 74.08%	6,007 $815,000
Q3 2018 Nov 13, 2018	SELL	$211.18 - $274.49 $1.46 Million - $1.9 Million	-6,923 Reduced 23.0%	23,173 $6.36 Million
Q2 2018 Aug 13, 2018	BUY	$150.77 - $207.98 $1.36 Million - $1.88 Million	9,016 Added 42.77%	30,096 $6.24 Million
Q1 2018 May 14, 2018	BUY	$138.63 - $182.62 $2.92 Million - $3.85 Million	21,080 New	21,080 $3.48 Million

276

18.6M

30.8K

5.2K

Ticker LGND
Exchange OTC
Sector Healthcare
Industry Biotechnology
Shares Outstandng 16,882,800
Market Cap $1.8B
Description
Ligand Pharmaceuticals Incorporated, a biopharmaceutical company, focuses on developing or acquiring technologies that help pharmaceutical companies to discover and develop medicines worldwide. Its commercial programs include Kyprolis and Evomela, which are used to treat multiple myeloma; Veklury for the treatment of moderate or severe COVID-19;...

Get notified when there are updates to the investment portfolio of Kepos Capital LP, based on Form 13F filings with the SEC.

Stay updated on Kepos Capital LP with notifications on news.